Want to see AU:ACW full AI Analyst Report?
Total Valuation
Actinogen Medical has a market cap or net worth of AU$228.58M. The enterprise value is AU$90.43.
Market CapAU$228.58M
Enterprise ValueAU$90.43
Share Statistics
Actinogen Medical has 3,874,163,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,874,163,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Actinogen Medical ’s return on equity (ROE) is -0.72 and return on invested capital (ROIC) is -58.92%.
Return on Equity (ROE)-0.72
Return on Assets (ROA)-0.52
Return on Invested Capital (ROIC)-58.92%
Return on Capital Employed (ROCE)-1.31
Revenue Per Employee0.00
Profits Per Employee-2.56M
Employee Count6
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Actinogen Medical is ―. Actinogen Medical ’s PEG ratio is 1.10.
PE Ratio―
PS Ratio0.00
PB Ratio4.83
Price to Fair Value4.83
Price to FCF-5.88
Price to Operating Cash Flow-11.28
PEG Ratio1.10
Income Statement
In the last 12 months, Actinogen Medical had revenue of 0.00 and earned -15.38M in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit-419.27K
Operating Income-28.11M
Pretax Income-28.05M
Net Income-15.38M
EBITDA-27.69M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -17.56M and capital expenditures -9.29K, giving a free cash flow of -17.57M billion.
Operating Cash Flow-17.56M
Free Cash Flow-17.57M
Free Cash Flow per Share>-0.01
Dividends & Yields
Actinogen Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.07
52-Week Price Change81.82%
50-Day Moving Average0.05
200-Day Moving Average0.04
Relative Strength Index (RSI)57.34
Average Volume (3m)5.23M
Important Dates
Actinogen Medical upcoming earnings date is Feb 24, 2027, TBA (Confirmed).
Last Earnings DateAug 27, 2026
Next Earnings DateFeb 24, 2027
Ex-Dividend Date―
Financial Position
Actinogen Medical as a current ratio of 3.45, with Debt / Equity ratio of 22.38%
Current Ratio3.45
Quick Ratio3.45
Debt to Market Cap0.05
Net Debt to EBITDA0.43
Interest Coverage Ratio-60.34
Taxes
In the past 12 months, Actinogen Medical has paid -12.67M in taxes.
Income Tax-12.67M
Effective Tax Rate0.45
Enterprise Valuation
Actinogen Medical EV to EBITDA ratio is -3.30, with an EV/FCF ratio of -5.20.
EV to Sales0.00
EV to EBITDA-3.30
EV to Free Cash Flow-5.20
EV to Operating Cash Flow-5.20
Balance Sheet
Actinogen Medical has AU$16.73M in cash and marketable securities with AU$4.78M in debt, giving a net cash position of AU$11.95M billion.
Cash & Marketable SecuritiesAU$16.73M
Total DebtAU$4.78M
Net CashAU$11.95M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Actinogen Medical is AU$0.08, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$0.08
Price Target Upside100.00% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast5.88%